11 essential heavy metals in renal tumor tissue and its possible relation to carcinogenesis: applying the scanning electron microscopy coupled with x-ray microanalysis technique

12 benefit of a second opinion for lung cancer: no metastasis to the kidney but a synchronous primary renal neoplasm

13 pazopanib-induced cutaneous leukocytoclastic vasculitis: an exclusion diagnosis of a multidisciplinary approach

14 thrombus-like tumor of renal cell carcinoma mimicking transitional cell carcinoma of kidney: a case report

15 metastatic renal cell carcinoma: a guide to therapy based on current evidence

16 breast and axillary lymph nodes metastasis five years after radical nephrectomy for renal cell carcinoma: a case report and review of the literature

17 overall survival in renal cell carcinoma after introduction of targeted therapies: a norwegian population-based study

18 renal cell carcinoma in von hippel–lindau disease—from tumor genetics to novel therapeutic strategies

19 xanthogranulomatous pyelonephritis and renal tubulopapillary adenomas: a rare coexistence

20 testicular metastasis from renal cell carcinoma: a case report and review of the literature

21 tumor necrosis factor-308 polymorphism with the risk and prognosis of non-hodgkin lymphomas: a meta-analysis study

22 new methods for predicting the sensitivity of renal cancer to immunotherapy on the basis of analysis of molecular genetic characteristics of a tumor

23 met in urological cancers

24 clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma

25 approach to spot overlapping problem in 2d-page revealed clinical and functional significance of rkip and mnsod in renal cell carcinoma

26 clinico-pathological features of incidentally detected and symptomatic renal cell carcinomas

27 Risk stratification and prognostication of renal cell carcinoma.

28 Immunohistochemical localization of nephrocalcin, a kidney-specific glycoprotein, to renal cell carcinoma.

29 Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy

30 Erratum: In vivo antitumor activity of a novel acetazolamide-cryptophycin conjugate for the treatment of renal cell carcinoma (ACS Omega (2018) 3:11 (14726-14731) DOI: 10.1021/acsomega.8b02350)

31 Dietary fiber, glycemic index, glycemic load and renal cell carcinoma risk

32 A large bone metastasis as an initial presentation of renal cell carcinoma.

33 Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology

34 Radiomics of small renal masses on multiphasic CT: accuracy of machine learning-based classification models for the differentiation of renal cell carcinoma and angiomyolipoma without visible fat.

35 Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.

36 Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.

37 Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.

38 The results of organ-preserving treatment of patients with localized renal cell carcinoma according to the original methodology

39 Methylation of 10 miRNA genes in clear cell renal cell carcinoma and their diagnostic value

40 [Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery].

41 A 10-Year Old Girl with Resistant Hypertension without Significant Indication of an Underlying Renal Cell Carcinoma, Misdiagnosed as Malaria.

42 Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature

43 Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

44 The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan

45 Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature.

46 Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

47 Aristolochic Acid in the Etiology of Renal Cell Carcinoma.

48 Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.

49 Renal Cell Carcinoma During Pregnancy: Letter to the Editor

50 Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.

51 A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma

52 Cytopathology of Xp11 translocation renal cell carcinoma: a report of 5 cases.

53 First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial

54 The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

55 microrna-34a: a key regulator in the hallmarks of renal cell carcinoma

56 checkpoint molecule pd-1-assisted cd8+ t lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

57 metastatic renal cell carcinoma in the sinonasal region: a case report

58 molecular targeted therapy in advanced renal cell carcinoma: a review of its recent past and a glimpse into the near future

59 stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma

60 spontaneous rupture of renal cell carcinoma: a series of three cases

61 identification of biomarkers for stage prediction in papillary renal cell carcinoma

62 gene expression profile of renal cell carcinoma clear cell type

63 robotic-assisted laparoscopic partial nephrectomy for small renal cell carcinoma: chi mei medical center experience

64 the relationship between ala16val single gene polymorphism and renal cell carcinoma

65 usefulness of resistive index on spectral doppler ultrasonography in the detection of renal cell carcinoma in patients with end-stage renal disease

66 synchronous primary renal cell carcinoma and pancreatic ductal adenocarcinoma: case report and literature review

67 3d texture analysis in renal cell carcinoma tissue image grading

68 An optimal prognostic model based on gene expression for clear cell renal cell carcinoma.

69 identification of biomarkers associated with pathological stage and prognosis of clear cell renal cell carcinoma by co-expression network analysis

70 unclassified renal cell carcinoma with medullary phenotype versus renal medullary carcinoma: lessons from diagnosis in an italian man found to harbor sickle cell trait

71 serum and urine biomarkers for human renal cell carcinoma

72 growth pattern of clear cell renal cell carcinoma in patients with delayed surgical intervention: fast growth rate correlates with high grade and may result in poor prognosis

73 imaging tumour thrombus of clear cell renal cell carcinoma: fdg pet or psma pet? direct in vivo comparison of two technologies

74 renal cell carcinoma with synchronous metastasis to the calcaneus and metachronous metastases to the ovary and gallbladder

75 vaginal bleeding as initial presentation of an aggressive renal cell carcinoma: a case report and review of the literature

76 expression and functional characterization of the bnip3 protein in renal cell carcinomas

77 transitional cell carcinoma of the renal pelvis with synchronous ipsilateral papillary renal cell carcinoma: case report and review

78 reversible posterior leukoencephalopathy syndrome developing after restart of sunitinib therapy for metastatic renal cell carcinoma

79 radiomics analysis on flt-pet/mri for characterization of early treatment response in renal cell carcinoma: a proof-of-concept study

80 clinical and prognostic effect of plasma fibrinogen in renal cell carcinoma: a meta-analysis

81 clear cell renal cell carcinoma with intratumoral granulomatous reaction: a case report and review of the literature

82 hyper ige syndrome and renal cell carcinoma

83 arterial embolization for spontaneous rupture of renal cell carcinoma

84 temporal identification of dysregulated genes and pathways in clear cell renal cell carcinoma based on systematic tracking of disrupted modules

85 use of a combined retroperitoneoscopic and transperitoneal laparoscopic technique for the management of renal cell carcinoma with level i tumor thrombi

86 inter and intratumour heterogeneity: a barrier to individualised medical therapy in renal cell carcinoma?

87 aberrant expression of metallothioneins in clear cell renal cell carcinomas

88 carbonic anhydrase ix is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray

89 new monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma

90 fas-induced apoptosis of renal cell carcinoma is mediated by apoptosis signal-regulating kinase 1 via mitochondrial damage-dependent caspase-8 activation

91 primary renal lymphoma mimicking renal cell carcinoma

92 osseous metaplasia and bone marrow elements in a case of renal cell carcinoma

93 detection of the tnfsf members baff, april, tweak and their receptors in normal kidney and renal cell carcinomas

94 postoperative adjuvant sorafenib or sunitinib for nonmetastatic renal cell carcinoma with venous tumor thrombus: a prospective cohort study

95 pediatric papillary renal cell carcinoma in a horseshoe kidney: a case report with review of the literature

96 the role of surgery in renal cell carcinoma with pancreatic metastasis

97 hereditary leiomyomatosis with renal cell carcinoma

98 How accurate is radiological imaging for perirenal fat and renal vein invasion in renal cell carcinoma?

99 Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease

100 Can Systemic Immune-Inflammation Index Create a New Perspective for the IMDC Scoring System in Patients with Metastatic Renal Cell Carcinoma?

101 First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely

Keyword Connections

Journals

Research Groups

Bibliographies